Atlas Trials

Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)

Clinical trial NCT03242928 · COMPLETED

Trial details

NCT number
NCT03242928
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cocaine-related Disorder
Start date
2017-12-04
Primary completion
2019-12-16
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.